Literature DB >> 22228704

REST regulates oncogenic properties of glioblastoma stem cells.

Mohamed M Kamal1, Pratheesh Sathyan, Sanjay K Singh, Pascal O Zinn, Anantha L Marisetty, Shoudan Liang, Joy Gumin, Hala Osman El-Mesallamy, Dima Suki, Howard Colman, Gregory N Fuller, Frederick F Lang, Sadhan Majumder.   

Abstract

Glioblastoma multiforme (GBM) tumors are the most common malignant primary brain tumors in adults. Although many GBM tumors are believed to be caused by self-renewing, glioblastoma-derived stem-like cells (GSCs), the mechanisms that regulate self-renewal and other oncogenic properties of GSCs are only now being unraveled. Here we showed that GSCs derived from GBM patient specimens express varying levels of the transcriptional repressor repressor element 1 silencing transcription factor (REST), suggesting heterogeneity across different GSC lines. Loss- and gain-of-function experiments indicated that REST maintains self-renewal of GSCs. High REST-expressing GSCs (HR-GSCs) produced tumors histopathologically distinct from those generated by low REST-expressing GSCs (LR-GSCs) in orthotopic mouse brain tumor models. Knockdown of REST in HR-GSCs resulted in increased survival in GSC-transplanted mice and produced tumors with higher apoptotic and lower invasive properties. Conversely, forced expression of exogenous REST in LR-GSCs produced decreased survival in mice and produced tumors with lower apoptotic and higher invasive properties, similar to HR-GSCs. Thus, based on our results, we propose that a novel function of REST is to maintain self-renewal and other oncogenic properties of GSCs and that REST can play a major role in mediating tumorigenicity in GBM.
Copyright © 2011 AlphaMed Press.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22228704      PMCID: PMC4039365          DOI: 10.1002/stem.1020

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  52 in total

1.  Engineering the brain tumor microenvironment enhances the efficacy of dendritic cell vaccination: implications for clinical trial design.

Authors:  Yohei Mineharu; Gwendalyn D King; A K M G Muhammad; Serguei Bannykh; Kurt M Kroeger; Chunyan Liu; Pedro R Lowenstein; Maria G Castro
Journal:  Clin Cancer Res       Date:  2011-06-01       Impact factor: 12.531

2.  The master negative regulator REST/NRSF controls adult neurogenesis by restraining the neurogenic program in quiescent stem cells.

Authors:  Zhengliang Gao; Kerstin Ure; Peiguo Ding; Mostafa Nashaat; Laura Yuan; Jing Ma; Robert E Hammer; Jenny Hsieh
Journal:  J Neurosci       Date:  2011-06-29       Impact factor: 6.167

Review 3.  Emerging monoclonal antibody therapies for malignant gliomas.

Authors:  David E Gerber; John Laterra
Journal:  Expert Opin Investig Drugs       Date:  2007-04       Impact factor: 6.206

4.  The neuronal repressor REST/NRSF is an essential regulator in medulloblastoma cells.

Authors:  P Lawinger; R Venugopal; Z S Guo; A Immaneni; D Sengupta; W Lu; L Rastelli; A Marin Dias Carneiro; V Levin; G N Fuller; Y Echelard; S Majumder
Journal:  Nat Med       Date:  2000-07       Impact factor: 53.440

5.  SCFbeta-TRCP controls oncogenic transformation and neural differentiation through REST degradation.

Authors:  Thomas F Westbrook; Guang Hu; Xiaolu L Ang; Peter Mulligan; Natalya N Pavlova; Anthony Liang; Yumei Leng; Rene Maehr; Yang Shi; J Wade Harper; Stephen J Elledge
Journal:  Nature       Date:  2008-03-20       Impact factor: 49.962

6.  REST maintains self-renewal and pluripotency of embryonic stem cells.

Authors:  Sanjay K Singh; Mohamedi N Kagalwala; Jan Parker-Thornburg; Henry Adams; Sadhan Majumder
Journal:  Nature       Date:  2008-03-23       Impact factor: 49.962

7.  Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts.

Authors:  J Graeme Hodgson; Ru-Fang Yeh; Amrita Ray; Nicholas J Wang; Ivan Smirnov; Mamie Yu; Sujatmi Hariono; Joachim Silber; Heidi S Feiler; Joe W Gray; Paul T Spellman; Scott R Vandenberg; Mitchel S Berger; C David James
Journal:  Neuro Oncol       Date:  2009-01-12       Impact factor: 12.300

Review 8.  Malignant astrocytic glioma: genetics, biology, and paths to treatment.

Authors:  Frank B Furnari; Tim Fenton; Robert M Bachoo; Akitake Mukasa; Jayne M Stommel; Alexander Stegh; William C Hahn; Keith L Ligon; David N Louis; Cameron Brennan; Lynda Chin; Ronald A DePinho; Webster K Cavenee
Journal:  Genes Dev       Date:  2007-11-01       Impact factor: 11.361

9.  An extended transcriptional network for pluripotency of embryonic stem cells.

Authors:  Jonghwan Kim; Jianlin Chu; Xiaohua Shen; Jianlong Wang; Stuart H Orkin
Journal:  Cell       Date:  2008-03-21       Impact factor: 41.582

10.  Control of chromosome stability by the beta-TrCP-REST-Mad2 axis.

Authors:  Daniele Guardavaccaro; David Frescas; N Valerio Dorrello; Angelo Peschiaroli; Asha S Multani; Timothy Cardozo; Anna Lasorella; Antonio Iavarone; Sandy Chang; Eva Hernando; Michele Pagano
Journal:  Nature       Date:  2008-03-20       Impact factor: 49.962

View more
  43 in total

1.  Phosphatase activity of small C-terminal domain phosphatase 1 (SCP1) controls the stability of the key neuronal regulator RE1-silencing transcription factor (REST).

Authors:  Nathaniel Tate Burkholder; Joshua E Mayfield; Xiaohua Yu; Seema Irani; Daniel K Arce; Faqin Jiang; Wendy L Matthews; Yuanchao Xue; Yan Jessie Zhang
Journal:  J Biol Chem       Date:  2018-09-14       Impact factor: 5.157

2.  REST represses miR-124 and miR-203 to regulate distinct oncogenic properties of glioblastoma stem cells.

Authors:  Anantha L Marisetty; Sanjay K Singh; Tran N Nguyen; Cristian Coarfa; Bin Liu; Sadhan Majumder
Journal:  Neuro Oncol       Date:  2017-04-01       Impact factor: 12.300

3.  Cancer stem cells in glioma: challenges and opportunities.

Authors:  Jialiang Wang; Yufang Ma; Michael K Cooper
Journal:  Transl Cancer Res       Date:  2013-10-01       Impact factor: 1.241

4.  Feedback circuitry between miR-218 repression and RTK activation in glioblastoma.

Authors:  Lijoy K Mathew; Peiwei Huangyang; Vera Mucaj; Samuel S Lee; Nicolas Skuli; T S Karin Eisinger-Mathason; Kevin Biju; Bo Li; Sriram Venneti; Priti Lal; Justin D Lathia; Jeremy N Rich; Brian Keith; M Celeste Simon
Journal:  Sci Signal       Date:  2015-05-05       Impact factor: 8.192

5.  Molecular targeting of TRF2 suppresses the growth and tumorigenesis of glioblastoma stem cells.

Authors:  Yun Bai; Justin D Lathia; Peisu Zhang; William Flavahan; Jeremy N Rich; Mark P Mattson
Journal:  Glia       Date:  2014-06-07       Impact factor: 7.452

Review 6.  The impact of age on oncogenic potential: tumor-initiating cells and the brain microenvironment.

Authors:  Elizabeth A Stoll; Philip J Horner; Robert C Rostomily
Journal:  Aging Cell       Date:  2013-06-28       Impact factor: 9.304

7.  The tumor suppressor microRNA, miR-124a, is regulated by epigenetic silencing and by the transcriptional factor, REST in glioblastoma.

Authors:  Amanda Tivnan; Jack Zhao; Terrance G Johns; Bryan W Day; Brett W Stringer; Andrew W Boyd; Sarita Tiwari; Keith M Giles; Charlie Teo; Kerrie L McDonald
Journal:  Tumour Biol       Date:  2013-09-26

8.  miR-490 suppresses telomere maintenance program and associated hallmarks in glioblastoma.

Authors:  Omkar Suhas Vinchure; Kurt Whittemore; Deependra Kushwah; Maria A Blasco; Ritu Kulshreshtha
Journal:  Cell Mol Life Sci       Date:  2020-09-24       Impact factor: 9.261

Review 9.  Selective repression of gene expression in neuropathic pain by the neuron-restrictive silencing factor/repressor element-1 silencing transcription (NRSF/REST).

Authors:  Dianna E Willis; Meng Wang; Elizabeth Brown; Lilah Fones; John W Cave
Journal:  Neurosci Lett       Date:  2015-12-08       Impact factor: 3.046

Review 10.  Ubiquitination and deubiquitination of REST and its roles in cancers.

Authors:  Zhi Huang; Shideng Bao
Journal:  FEBS Lett       Date:  2012-05-05       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.